MDxHealth SA ROE 2018-2025 | MDXH

Current and historical return on equity (ROE) values for MDxHealth SA (MDXH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
MDxHealth SA ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-0.04B $0.01B -537.93%
2024-12-31 $-0.04B $0.02B -709.09%
2024-09-30 $-0.04B $0.02B -1228.57%
2024-06-30 $-0.04B $-0.01B -1120.00%
2024-03-31 $-0.04B $0.00B -683.33%
2023-12-31 $-0.04B $0.01B -279.37%
2023-06-30 $-0.04B -389.47%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.104B $0.090B
MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.022B 58.55
Tempus AI (TEM) United States $11.820B 0.00
Doximity (DOCS) United States $11.014B 50.99
Hims & Hers Health (HIMS) United States $9.614B 99.88
IRhythm Technologies (IRTC) United States $4.905B 0.00
Inspire Medical Systems (INSP) United States $3.910B 61.09
Hinge Health (HNGE) United States $3.661B 0.00
Privia Health (PRVA) United States $2.683B 183.42
Enovis (ENOV) United States $1.826B 10.18
Phreesia (PHR) United States $1.658B 0.00
Schrodinger (SDGR) United States $1.512B 0.00
Clover Health Investments (CLOV) United States $1.445B 0.00
Azenta (AZTA) United States $1.378B 64.06
Omnicell (OMCL) United States $1.363B 24.05
10x Genomics (TXG) United States $1.341B 0.00
Evolent Health (EVH) United States $1.247B 106.20
Claritev (CTEV) United States $0.667B 0.00
Fulgent Genetics (FLGT) United States $0.594B 0.00
Butterfly Network (BFLY) United States $0.497B 0.00
Veradigm (MDRX) United States $0.487B 0.00
Talkspace (TALK) United States $0.480B 143.50
Standard BioTools (LAB) United States $0.463B 0.00
Outset Medical (OM) United States $0.354B 0.00
TruBridge (TBRG) United States $0.346B 768.33
Nyxoah SA (NYXH) Belgium $0.264B 0.00
Health Catalyst (HCAT) United States $0.261B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.210B 0.00
KORU Medical Systems (KRMD) United States $0.164B 0.00
EUDA Health Holdings (EUDA) Singapore $0.139B 0.00
American Well (AMWL) United States $0.114B 0.00
CareCloud (CCLD) United States $0.109B 4.15
Pulmonx (LUNG) United States $0.108B 0.00
111 (YI) China $0.067B 0.00
HeartBeam (BEAT) United States $0.050B 0.00
P3 Health Partners (PIII) United States $0.043B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.043B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
Healthcare Triangle (HCTI) United States $0.013B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00